Related references
Note: Only part of the references are listed.Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression
Hanna Hlawaty et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Impaired Peroxisome Proliferator-activated Receptor-γ Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension
Lili Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db Mice
Mohan R. Dasu et al.
ENDOCRINOLOGY (2009)
The role of progenitor cells in the development of intimal hyperplasia
Shirling Tsai et al.
JOURNAL OF VASCULAR SURGERY (2009)
PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway
Yuanyuan Ji et al.
LABORATORY INVESTIGATION (2009)
Innate immunity has a dual effect on vascular healing: Suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge
H. Epstein et al.
ATHEROSCLEROSIS (2008)
Mechanisms of intimal hyperplasia learned from a murine carotid artery ligation model
Le-Ning Zhang et al.
CURRENT VASCULAR PHARMACOLOGY (2008)
High Glucose Induces Toll-Like Receptor Expression in Human Monocytes Mechanism of Activation
Mohan R. Dasu et al.
DIABETES (2008)
Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor γ and nuclear factor-κB in macrophages
Brian M. Necela et al.
IMMUNOLOGY (2008)
Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy
Xiangbin Xu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
An essential role for gp130 in neointima formation following arterial injury
Dong Wang et al.
CIRCULATION RESEARCH (2007)
Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways
Feng-Yen Lin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery
Minoru Takaoka et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury
Akira Shimamoto et al.
CIRCULATION (2006)
Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4
Rick de Graaf et al.
MICROBES AND INFECTION (2006)
Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes - Distinct responses to stimuli
DXF Deng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Activation of peroxisome proliferator-activated receptor γ suppresses telomerase activity in vascular smooth muscle cells
D Ogawa et al.
CIRCULATION RESEARCH (2006)
Impaired expression of PPARγ protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats
C Xiong et al.
LIFE SCIENCES (2005)
Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling
X Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Platelet-derived growth Factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation
E Millette et al.
CIRCULATION RESEARCH (2005)
Toll-like receptor 4 is involved in outward arterial remodeling
SCG Hollestelle et al.
CIRCULATION (2004)
Molecular regulation of vascular smooth muscle cell differentiation in development and disease
GK Owens et al.
PHYSIOLOGICAL REVIEWS (2004)
Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus
JS Sidhu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes
JW Phillips et al.
CIRCULATION (2003)
Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-δ and peroxisome proliferator-activated receptor-γ
Y Takata et al.
CIRCULATION RESEARCH (2002)
LPS induction of gene expression in human monocytes
M Guha et al.
CELLULAR SIGNALLING (2001)
Peroxisome proliferator-activated receptor γ ligands inhibit retinoblastoma phosphorylation and G1 → S transition in vascular smooth muscle cells
S Wakino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II
Y Hattori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats
A Chajara et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Expression and function of PPARγ in rat and human vascular smooth muscle cells
RE Law et al.
CIRCULATION (2000)
Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators
V Pasceri et al.
CIRCULATION (2000)
Share Paper
